A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

NCT04132557 · clinicaltrials.gov ↗

COMPLETED

Status

430000

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: Methylphenidate
DRUG: Lisdexamfetamine
DRUG: Atomoxetine
DRUG: Amphetamine
DRUG: Dextroamphetamine

Sponsor

Janssen Research & Development, LLC